01 1Micro Labs Limited
01 1GLIMEPIRIDE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-08-15
Pay. Date : 2022-07-08
DMF Number : 37221
Submission : 2022-06-30
Status : Active
Type : II
20
Micro Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is GLIMEPIRIDE USP, with a corresponding US DMF Number 37221.
Remarkably, this DMF maintains an Active status since its submission on June 30, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 15, 2022, and payment made on July 08, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
